552. Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study)

BACKGROUND: The COVID-19 epidemic has been repeated worldwide; however, easily accessible treatment options for patients with mild COVID-19 remain limited. Since the Lactococcus lactis strain plasma (LC- Plasma) enhances both the innate and acquired immune systems through the activation of plasmacyt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kazuko, Inoue, Tsuyoshi, Jounai, Kenta, Tsuji, Ryohei, Fujiwara, Daisuke, Iwanaga, Naoki, Ikeda, Takaya, Sawai, Toyomitsu, Nagayoshi, Yosuke, Hashiguchi, Koji, Futsuki, Yohji, Matsubara, Yuichi, Hosogaya, Naoki, Yanagihara, Katsunori, Izumikawa, Koichi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677221/
http://dx.doi.org/10.1093/ofid/ofad500.621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677221/
http://dx.doi.org/10.1093/ofid/ofad500.621

Ejemplares similares